![]() |
|
|
Vol. 27, Issue 12, 1466-1469, December 1999
Fred Hutchinson Cancer Research Center, Seattle, Washington
(J.P.G., J.T.S.); Department of Pharmaceutics, University of
Washington, Seattle, Washington (J.P.G., J.T.S.); and Division of
Gastroenterology and Nutrition, Children's Hospital of
Philadelphia, Philadelphia, Pennsylvania (C.A.L., R.N.B.)
The relationship between age and busulfan apparent oral clearance
(Cl/F) expressed relative to adjusted ideal body weight and body
surface area (bsa) was evaluated in 135 children aged 0 to 16 years
undergoing hematopoietic stem cell transplantation for various
disorders. Busulfan plasma levels were measured by gas
chromatography-mass spectrometry after the first daily dose of
the 4-day dosing regimen. Cl/F expressed relative to adjusted ideal
body weight (ml/min/kg) and bsa (ml/min/m2) was
lower in 9- to 16-year-old (y.o.) compared with 0- to 4-y.o. children
(49 and 30%; p < .001). We hypothesized that the
greater busulfan Cl/F observed in young children was in part due to
enhanced (first-pass intestinal) metabolism. Busulfan conjugation rate was compared in incubations with human small intestinal biopsy specimens from healthy young (1- to 3-y.o.) and older (9- to 17-y.o.) children. Villin content in biopsy specimens was determined by Western
blot and busulfan conjugation rate was expressed relative to villin
content to control for differences in epithelial cell content in pinch
biopsies. Intestinal biopsy specimens from young children had a 77%
higher busulfan conjugation rate (p = .037) compared with older children. We have previously shown that
glutathione-S-transferase (GST) A1-1 is the
major isoform involved in busulfan conjugation, and that this enzyme is
expressed uniformly along the length of adult small intestine. Thus,
the greater busulfan conjugation activity in intestinal biopsies of the
young children was most likely due to enhanced GSTA1-1 expression. We
conclude that age dependence in busulfan Cl/F appears to result at
least in part from enhanced intestinal GSTA1-1 expression in young children.
This article has been cited by other articles:
![]() |
L. Johnson, P. J. Orchard, K. S. Baker, R. Brundage, Q. Cao, X. Wang, E. Langer, S. F.-E. Maasah, J. A. Ross, R. Remmel, et al. Glutathione S-Transferase A1 Genetic Variants Reduce Busulfan Clearance in Children Undergoing Hematopoietic Cell Transplantation J. Clin. Pharmacol., September 1, 2008; 48(9): 1052 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kearns, S. M. Abdel-Rahman, S. W. Alander, D. L. Blowey, J. S. Leeder, and R. E. Kauffman Developmental Pharmacology -- Drug Disposition, Action, and Therapy in Infants and Children N. Engl. J. Med., September 18, 2003; 349(12): 1157 - 1167. [Full Text] [PDF] |
||||